Simon Matthias, Hagemann Anne, Gajadin Sanjana, Signorelli Francesco, Vincent Arnaud J P E
Dept. of Neurosurgery, Bethel Clinic, University of Bielefeld Medical Center OWL, Bielefeld, Germany.
Society for Epilepsy Research, Bielefeld, Germany.
Brain Spine. 2024 May 15;4:102828. doi: 10.1016/j.bas.2024.102828. eCollection 2024.
INTRODUCTION: The appropriate surgical management of insular gliomas is controversial. Management strategies vary considerably between centers. RESEARCH QUESTION: To provide robust resection, functional and epilepsy outcome figures, study growth patterns and tumor classification paradigms, analyze surgical approaches, mapping/monitoring strategies, surgery for insular glioblastoma, as well as molecular findings, and to identify open questions for future research. MATERIAL AND METHODS: On behalf of the EANS Neuro-oncology Section we performed a systematic review and meta-analysis (using a random-effects model) of the more current (2000-2023) literature in accordance with the PRISMA guidelines. RESULTS: The pooled postoperative motor and speech deficit rates were 6.8% and 3.6%. There was a 79.6% chance for postoperative epilepsy control. The postoperative KPI was 80-100 in 83.5% of cases. Functional monitoring/mapping paradigms (which may include awake craniotomies) seem mandatory. (Additional) awake surgery may result in slightly better functional but also worse resection outcomes. Transcortical approaches may carry a lesser rate of (motor) deficits than transsylvian surgeries. DISCUSSION AND CONCLUSIONS: This paper provides an inclusive overview and analysis of current surgical management of insular gliomas. Risks and complication rates in experienced centers do not necessarily compare unfavorably with the results of routine neuro-oncological procedures. Limitations of the current literature prominently include a lack of standardized outcome reporting. Questions and issues that warrant more attention include surgery for insular glioblastomas and how to classify the various growth patterns of insular gliomas.
引言:岛叶胶质瘤的恰当手术治疗存在争议。各中心的管理策略差异很大。 研究问题:提供有力的切除、功能及癫痫预后数据,研究生长模式和肿瘤分类范式,分析手术入路、定位/监测策略、岛叶胶质母细胞瘤的手术治疗以及分子学发现,并确定未来研究的开放性问题。 材料与方法:代表欧洲神经外科协会神经肿瘤学分会,我们按照PRISMA指南对最新的(2000 - 2023年)文献进行了系统综述和荟萃分析(采用随机效应模型)。 结果:术后运动和言语功能缺损的合并发生率分别为6.8%和3.6%。术后癫痫得到控制的概率为79.6%。83.5%的病例术后关键性能指标(KPI)为80 - 100。功能监测/定位范式(可能包括清醒开颅手术)似乎是必要的。(额外的)清醒手术可能会使功能结果稍好,但切除结果也更差。经皮质入路导致(运动)功能缺损的发生率可能低于经外侧裂手术。 讨论与结论:本文对岛叶胶质瘤当前的手术治疗进行了全面的概述和分析。在经验丰富的中心,风险和并发症发生率与常规神经肿瘤手术的结果相比不一定不利。当前文献的局限性主要包括缺乏标准化的结果报告。值得更多关注的问题包括岛叶胶质母细胞瘤的手术治疗以及如何对岛叶胶质瘤的各种生长模式进行分类。
J Neurooncol. 2021-2
Neurosurg Rev. 2019-5-19
J Neurol Surg A Cent Eur Neurosurg. 2024-1
Epilepsy Behav Rep. 2023-1-13
J Neurosurg. 2023-7-1
Oper Neurosurg (Hagerstown). 2022-6-1